-
Rural Health Transformation with Connected RPMDesigned for the Rural Health Transformation Program, Carematix delivers cellular-enabled Remote Patient Monitoring and chronic care solutions—expanding.
Learn More -
Workflow Automation for a Virtual Hypertension Management ProgramHypertension is a modifiable risk factor for numerous comorbidities and treating hypertension can greatly improve health outcomes. We sought to increase the efficiency of a virtual hypertension management program through workflow automation processes.
Read More -
Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care NetworkQuestion Does an entirely remote hypertension and hypercholesterolemia program implemented across a large diverse health network help ensure equal access to care?
Read More -
Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 PandemicThe COVID‐19 pandemic disrupted traditional health care; one fallout was a drastic decrease in blood pressure (BP) assessment. We analyzed the pandemic’s impact on our existing remote hypertension management program’s effectiveness and adaptability.
Read More -
Carematix Unveils Revolutionary Cellular Weight Scale with Advanced Weight Asymmetry TechnologyCarematix, a leading innovator in remote patient monitoring (RPM) healthcare technology is proud to announce its new patented Cellular Weight Scale. This state-of-the-art and easy-to-use device is designed to transform health monitoring by tracking daily weight measurements and weight asymmetry, offering unmatched accuracy and convenience for both patients and healthcare providers.
Read More -
Carematix Launches the World’s First Connected Blinded Blood Pressure Monitor and Scale for Clinical TrialsCarematix, a leading innovator in remote patient monitoring (RPM) healthcare technology announced the launch.
Read More -
Carematix launches remote patient monitoring scaleCarematix’s Cellular Weight Scale (CWS) will aid in the development of patient care plans for a variety of conditions.
has unveiled its Cellular Weight Scale, a new remote patient monitoring.
Read More -
Innovaccer Partners With Carematix to Emphasize Remote Patient Monitoring on the Innovaccer Health CloudInnovaccer Inc., a leading healthcare technology company, recently announced its partnership with healthcare IoT devices company, Carematix to integrate remote patient monitoring.
Read More -
Blipcare Launches Blip BP 800, Cellular Blood Pressure Monitor Specifically Designed for Remote Patient Monitoring (RPM)Blipcare, the company that developed the world’s first Wi-Fi blood pressure monitor, today announced the availability of its new cellular blood pressure monitor, the Blip BP 800.
Read More -
Association between Self-Weighing and Percent Weight ChangeBackground: To date, no investigators have examined electronically recorded self-weighing.
Read More -
Digital health empowers diabetes patientsA three-month experiment in Canada with bimonthly text messages, a Web portal, and home-based medical devices produced an average weight decrease of 3.5 pounds and a mean reduction in hemoglobin A1c levels from 7.41 to 6.77 percent in Type 2 diabetics.
Read More -
Carematix Releases Blipcare Wireless Weight ScaleAccording to a statement in Health Data Management, Ochsner Health System in New Orleans developed a program utilizing a Carematix Blipcare wireless weight scale for remote patient monitoring to cut readmissions of heart failure patients by 40 percent. The program began in Feb. 2014, when Ochsner sent more than 100 heart failure patients home with a Carematix Blipcare wireless scale.
Read More -
Carematix Chronic Care Monitoring Solution Helps Reduce Ochsner Hospital’s 30 Day Readmissions by 40%According to a statement in Health Data Management, Ochsner Health System in New Orleans, developed a program.
Read More -
Using wireless scales to decrease readmissionsNew Orleans-based Ochsner Health system developed a program using wireless weight scales that helped decrease its heart failure 30-day readmission rates by 40 percent. Here are three things to know about the program.
Read More -
Researchers Set to Launch Phase 3 Trial for Parkinson’sA $23 million grant from the National Institutes of Health will support a new Phase 3 clinical trial to evaluate the drug isradipine as a potential new treatment for Parkinson’s disease.
Read More -
A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health.
Read More -
Clinical Effectiveness, Access to, and Satisfaction with Care Using a Telehomecare Substitution Intervention: A Randomized Controlled TrialHospitalization accounts for 70% of heart failure (HF) costs; readmission rates at 30 days are 24% and rise to 50% by 90 days.
Read More -
Treatment Intensification in a Hypertension Telemanagement Trial – Clinical Inertia or Good Clinical Judgment?Clinical inertia represents a barrier to hypertension management. As part of a hypertension tele-management trial designed to overcome clinical inertia.
Read More -
Home Blood Pressure Management and Improved Blood Pressure Control Results From a Randomized Controlled TrialBackground To determine which of 3 interventions was most effective in improving.
Read More -
Telemonitoring in PatientsAims: Results from previous studies suggest that remote monitoring.
Read More -
TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-DThis feasibility study will investigate the clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) and weight and blood pressure (BP) external telemonitoring (ETM).
Read More -
Self-Efficacy in Weight Loss Treatment (SELF)This randomized clinical trial of weight loss treatment will examine if adding personalized, one-on-one treatment sessions to standard.
Read More
Publications
Rural Health Transformation with Connected RPM
Workflow Automation for a Virtual Hypertension Management Program
Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network
Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 Pandemic
Carematix Unveils Revolutionary Cellular Weight Scale with Advanced Weight Asymmetry Technology
Carematix Launches the World’s First Connected Blinded Blood Pressure Monitor and Scale for Clinical Trials
Carematix launches remote patient monitoring scale
Innovaccer Partners With Carematix to Emphasize Remote Patient Monitoring on the Innovaccer Health Cloud
Carematix Chronic Care Monitoring Solution Helps Reduce Ochsner Hospital’s 30 Day Readmissions by 40%
